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The International Fetal and Newborn Growth Consortium for the
21st Century (INTERGROWTH-21st) is a large-scale, population-
based, multicentre project involving health institutions from eight
geographically diverse countries, which aims to assess fetal,
newborn and preterm growth under optimal conditions. Given
the multicentre nature of the project and the expected number of
preterm births, it is vital that all centres follow the same
standardised clinical care protocols to assess and manage preterm
infants, so as to ensure maximum validity of the resulting
standards as indicators of growth and nutrition with minimal
confounding. Moreover, it is well known that evidence-based
clinical practice guidelines can reduce the delivery of
inappropriate care and support the introduction of new
knowledge into clinical practice. The INTERGROWTH-21st
Neonatal Group produced an operations manual, which reflects
the consensus reached by members of the group regarding
standardised definitions of neonatal morbidities and the minimum
standards of care to be provided by all centres taking part in the
project. The operational definitions and summary management
protocols were developed by consensus through a Delphi process
based on systematic reviews of relevant guidelines and
management protocols by authoritative bodies. This paper
describes the process of developing the Basic Neonatal Care
Manual, as well as the morbidity definitions and standardised
neonatal care protocols applied across all the INTERGROWTH-
21st participating centres. Finally, thoughts about implementation
strategies are presented.
Keywords Neonatal care protocols, neonatal guidelines, neonatal
morbidity definitions, preterm growth, preterm infants, standards
of care.
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Introduction
Of the 8.8 million deaths of children under five in 2008,
41% (3.6 million) occurred within the neonatal period and
almost 12% (1.03 million, uncertainty range 0.72–1.22 mil-
lion) were related to prematurity.1 Data on the global bur-
den of prematurity also point to a considerable, yet
unspecified, burden of morbidity.2 It is estimated that, in
2005, preterm births accounted for almost 13 million births
worldwide; 85% (11 million) of these occurred in Africa
and Asia.3 Where good-quality trend data are available,
these also suggest that the rates of preterm birth are rising.
Given the increasing evidence that size at birth and
subsequent postnatal growth velocity may be critically
related to long-term neurological and metabolic outcomes,
the development of normative standards is an important
step in targeting interventions. The development and util-
isation of growth charts for preterm infants is a necessary
step towards appropriate evaluation of their postnatal
growth in clinical practice.
The International Fetal and Newborn Growth Consor-
tium for the 21st Century (INTERGROWTH-21st) is a
large-scale, population-based, multicentre project involving
health institutions from eight geographically diverse coun-




tries. The project aims to assess fetal, newborn and preterm
growth under optimal conditions, in a manner similar to
that adopted by the World Health Organization (WHO)
Multicentre Growth Reference Study (MGRS).4 The
INTERGROWTH-21st Project has three major components,
which were designed to create: (1) longitudinally derived,
prescriptive, international, fetal growth standards using
both clinical and ultrasound measures; (2) preterm, postna-
tal growth standards for those infants born at ≥26+0 but
<37+0 weeks of gestation in the longitudinal cohort; and
(3) birthweight-for-gestational-age standards derived from
all newborns delivering at the study sites over an approxi-
mately 12 month period.5
Given the multicentre nature of the project and the
expected number of preterm births, it was vital that all cen-
tres followed the same, standardised, clinical care protocols
to assess and manage preterm infants, so as to ensure max-
imum validity of the resulting standards as indicators of
growth and nutrition. All infants in the Preterm Postnatal
Follow-up Study (PPFS) are monitored for the first
8 months of life using the same protocol and set of anthro-
pometric measurements as in MGRS.6 Although the stan-
dardisation of anthropometric measurements is a central
element of the project, given the importance of optimising
care for preterm infants, it was considered essential that all
the participating institutions used common definitions of
neonatal morbidities and followed standardised neonatal
care protocols. The implementation of common clinical
practice guidelines is an important prerequisite in defining
the context of nutrition and care for preterm infants.7
Development of the basic neonatal
care manual
The INTERGROWTH-21st Neonatal Group produced an
operations manual,5 which reflects the consensus reached by
members of the group regarding the definitions of neonatal
morbidities and the minimum standards of care to be pro-
vided by all centres taking part in the INTERGROWTH-21st
Project. The operational definitions and summary manage-
ment protocols were developed following a systematic pro-
cess of literature review and best fit of relevant guidelines.
This process was undertaken by collaborating neonatologists
and overseen by a core group led by Prof. ZA Bhutta. Specific
areas were reviewed by group members and a systematic
search of existing management protocols in participating
centres was undertaken. All subgroups were encouraged to
develop key definitions and relevant management recom-
mendations for implementation. All core definitions and
protocols were presented and consensus was reached when
the Neonatal Group met in Oxford in July 2009. The agreed
protocols and operational definitions were then developed
into a Basic Neonatal Care Manual and implemented after a
pilot phase. Finally, in April 2011, the manual was reviewed
during the Neonatal Group’s second meeting. Figure 1 sum-
marises the overall process undertaken.
This paper describes the consensus-based components of
the manual, including the morbidity definitions and standar-
dised neonatal care protocols that were implemented uni-
formly across all participating INTERGROWTH-21st centres.
Summary of neonatal morbidities and
management recommendations
In this section, a brief overview of the main topics in the
manual is given. For the sake of brevity, not all the sections
are summarised here, and only the main respiratory and
neurological conditions are described in detail. Summary
paragraphs about nutrition, thermoregulation, anaemia
requiring transfusion, hyperbilirubinaemia and sepsis are
also included.
Administration of antenatal steroids to women at
risk of preterm delivery
The group reviewed the evidence for the use of antenatal
steroids to prevent prematurity-associated, respiratory dis-
tress syndrome. According to the most recent guidelines8,9
and established findings from a systematic review,10 a single
course of steroids should be administered as a routine pre-
ventive intervention to all women, between 24 and
34 weeks of gestation, who are at risk of preterm delivery
within 7 days, and to all women with premature rupture of
membranes at <32 weeks of gestation. Repeated doses must
be used with caution as a recent meta-analysis showed
Existing guidelines 
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(Neonatal Group meeting 2011)
Figure 1. Preparation of the neonatal care manual.
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significantly impaired fetal growth compared with pla-
cebo,11 which may lead to long-term neurodevelopmental
consequences. The most recent review of the evidence12
suggests that antenatal steroids administered to at-risk
mothers decrease neonatal mortality among preterm infants
(<36 weeks of gestation) by 31% (relative risk [RR] 0.69;
95% confidence interval [95% CI] 0.58–0.81). The meta-
analysis of four randomised controlled trials from middle-
income countries also indicates a 53% mortality reduction
(RR 0.47; 95% CI 0.35–0.64) and 37% morbidity reduction
(RR 0.63; 95% CI 0.49–0.81). In addition, recent data sug-
gest that the use of antenatal steroids is both effective and
safe in women with preterm premature rupture of mem-
branes plus chorioamnionitis and no increased risk of com-
plications.13 A standard protocol of administration of
antenatal steroids was, therefore, agreed for implementation
across the INTERGROWTH-21st sites.
Respiratory tract disorders in the early neonatal
period
There are several morbidities commonly observed in the
preterm neonate, including:
 Transient Tachypnoea of Newborn—a parenchymal lung
disorder characterised by pulmonary oedema resulting from
delayed resorption and clearance of fetal alveolar fluid.
Onset usually within 2 hours of delivery. X-ray characteris-
tics: increased lung volumes, prominent vascular markings
and fluid in the interlobar fissure.14
 Respiratory Distress Syndrome—diagnosed if each of the
following are present:
– Requires oxygen at 6 hours of life continuing to age
24 hours
– Demonstrates clinical features within first 24 hours
– Has need for respiratory support up to age 24 hours,
AND
– Has an abnormal chest X-ray within first 24 hours
consistent with surfactant deficiency, OR
– Has received surfactant therapy within the first
24 hours of life.15,16
 Meconium Aspiration Syndrome—respiratory distress in
an infant born through meconium-stained amniotic fluid,
whose symptoms cannot be otherwise explained. Can be
complicated by respiratory failure, pulmonary air leaks and
persistent pulmonary hypertension.14,17
The Neonatal Group also considered additional condi-
tions and agreed on a set of standard management proto-
cols described in the manual.5 As an illustration, the
respiratory distress syndrome management protocol is sum-
marised in Table 1.14,18,19
Birth asphyxia
Birth asphyxia remains a major killer in the neonatal per-
iod20 and can also be a significant burden in preterm
infants with high rates of mortality and sequelae.21 Given
the need for diagnostic specificity, we recommended the
definition of birth asphyxia in an infant satisfying at least
one of the following criteria: Apgar score ≤5 at 10 minutes;
mechanical ventilation or resuscitation at 10 minutes; cord
pH <7.1 or an arterial pH <7.1 or base deficit ≥12 within
60 minutes of birth; evidence of encephalopathy according
to Sarnat staging.22–25
Thermoregulation
Appropriate thermoregulation is key to the care and
growth of preterm infants. In order to ensure standard
management, the group considered a number of thresh-
olds24,26 and agreed on the following management proto-
cols.
At delivery
The delivery room or operating theatre is always too cold
for a very-low-birthweight newborn. Hence, the baby
should be thoroughly dried, wrapped, resuscitated and
moved to a warmer environment, as soon as possible.
Maintaining adequate thermoregulation for the preterm
infant in the immediate newborn period is dependent on:
 Adequate environmental temperature in delivery room
>25°C
 Use of warmers for infants <29 weeks of gestation or if
prolonged resuscitation is required
 Occlusive plastic wrapping at delivery for all infants
<32 weeks of gestation
 Hats and swaddling
 Maintaining temperature stability during stabilisation in
neonatal intensive care unit (NICU).
Incubator care
A closed incubator provides an infant with high ambient
temperature while allowing attendants to work at a lower,
more comfortable temperature. Recommended tempera-
tures and humidity grades for each gestational age at birth
are provided in the manual. These settings also depend on
whether the infant is clothed or naked, and on the infant’s
weight and postnatal age.
Weaning to crib
When the infant’s temperature is maintained within a nor-
mal range at low incubator temperatures (i.e. <34°C) and
heater output of <50%, then thermal aides can be slowly
weaned. They should be removed one at a time with effec-
tiveness assessed over 6–8 hours before making further
changes.
Initiation of feeding
The goal of the guideline, which is consistent with recent
reviews of the literature,27,28 is to promote exclusive breast-
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feeding of the preterm infant at the time of hospital dis-
charge. With this aim, the preferred feed is mother’s own
milk (from breast or expressed), followed by donor human
milk, and then preterm formula.
A starting volume of approximately 80 ml/kg/day is
indicated, with daily increases of 10–20 ml/kg to a maxi-
mum of approximately 160–180 ml/kg/day by the end of
the first week of life. For infants <32 weeks of gestation,
small amounts of trophic feeds (5–10 ml/kg/day) can be
introduced on the first day of life unless illness prevents
this. Milk can be given via a nasogastric tube either inter-
mittently or continuously. Although theoretical benefits
and risks of each method have been proposed, actual clin-
ical benefits and risks of the two methods cannot be reli-
ably discerned from the limited information available
from the randomised controlled trials to date.29 Therefore,
no specific recommendation is provided regarding this
issue.
The indicated duration of exclusive breastfeeding is
6 months in low-birthweight infants, accompanied by ade-
quate supplementation. Multicomponent fortifiers may be
useful in lower gestational age infants. Indications given
in the manual about feed volumes, progression and
human milk supplementation are mostly based on WHO
recommendations.27 Table 2 summarises recommendations
regarding daily enteral nutrients.
Other common neonatal morbidities
Respiratory tract disorders in the late neonatal period
 Apnoea of Prematurity—clinically significant apnoea in
infants is defined as breathing pauses that last for >20 sec-
onds, or for >10 seconds if associated with bradycardia or
oxygen desaturation14
 Bronchopulmonary Dysplasia—chronic supplemental oxy-
gen needs for >28 days OR chronic supplemental oxygen
needs at either 36 weeks postmenstrual age or discharge
from hospital, whichever comes first.14
Table 3 summarises the apnoea of prematurity manage-
ment protocol.
Hyperbilirubinaemia in preterm and low-
birthweight babies
Hyperbilirubinaemia is very common and usually benign in
term and late preterm (i.e. 35–36 weeks of gestation) new-
borns.30 Critical hyperbilirubinaemia is uncommon but has
the potential for causing long-term neurological impair-
ment.
Clinicians should ensure that all infants are routinely
monitored clinically for the development of jaundice. Mea-
surement of total serum bilirubin and/or total cutaneous
bilirubin should be performed in every newborn who
develops jaundice in the first 24 hours of life; further mon-
itoring of total serum bilirubin levels depends on the first
bilirubin value, the age of the infant and the evolution of
jaundice.31
Table 1. Management recommendations for respiratory distress syndrome (RDS)
Clinical condition Management recommendations
Respiratory distress
syndrome
Administration of surfactant: Surfactant should be given to infants with RDS as soon as possible after intubation
irrespective of antenatal steroid exposure or gestational age and prophylactic surfactant replacement should be
considered for extremely preterm infants at high risk of RDS, especially if they have not been exposed to antenatal steroids.
Use of nasal Continuous Positive Airway Pressure (nCPAP): Indicated for babies ≥27 weeks of gestation with low risk
of significant RDS or mild RDS on X-ray.Initial settings: 4–5 (max 7–8) cm H2O, fraction of inspired oxygen (FiO2)
0.4–0.5, flow 6–8 l/minute. Monitoring: Respiratory rate, work of breathing, colour/O2 saturation, perfusion, blood
pressure, chest expansion and pneumothorax on chest X-ray, blood gas, air leak syndrome. Consider intubation
during nCPAP: FiO2 >0.6 or more than one apnoeic episode per hour requiring stimulation, or if work of breathing
is significant.
Extubation to CPAP: Infant active, exhibits spontaneous respiratory effort and is not in respiratory failure (FiO2 <50%,
PCO2 <60 mmHg on low ventilator settings).
Weaning from CPAP: Wean to CPAP of 5 cm H2O and discontinue when infant is stable with FiO2 <0.30; recommence
CPAP if apnoea or FiO2 increases.
Table 2. Recommended daily enteral nutrients for preterm infants
>1000 g at birth
Nutrient Birth to 7 days Period after birth
stabilisation to term
Energy, kJ/kg (kcal/kg) 292–334 (70–80) 438–563 (105–135)
Protein, g/kg 1.0–3.0 3.0–3.6
Fat, g/kg 0.5–3.6 4.5–6.8
Carbohydrate, g/kg 5.0–20.0 7.5–15.5
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The basic pathophysiology of jaundice is the same in term
and preterm babies but lower gestational age infants are at
higher risk of developing hyperbilirubinaemia and, there-
fore, require close surveillance and monitoring. Total serum
bilirubin thresholds for intervention vary in term, late pre-
term and preterm (<35 weeks of gestation) newborns.
The American Academy of Pediatrics (AAP) has a guide-
line for newborns ≥35 weeks of gestation, but the manage-
ment of more preterm infants is still a grey zone; hence,
many institutions have their own guidelines. Those adopted
in this study are based on the AAP guidelines and confined
to newborns ≥35 weeks of gestation.31 Following the recent
publication of the National Institute for Health and Care
Excellence recommendations,32 a subcommittee of the Neo-
natal Group discussed whether or not to update the man-
ual; however, the decision was made to retain the AAP
guideline as the common protocol among the participating
centres.
Sepsis
There are various operational definitions of neonatal sepsis,
many dictated by a combination of blood culture positivity
and clinical features.33–36 For the INTERGROWTH-21st
Project, neonatal sepsis was defined as a clinical syndrome
of systemic illness accompanied by bacteraemia occurring
in the first month of life. Late onset sepsis was defined as
one or more positive blood cultures obtained after 3 days
of age from infants with clinical features of sepsis.
However, as culture-positive sepsis is relatively rare, a
physician-documented episode of sepsis sufficed for com-
parative purposes.
In the manual, guidelines are provided regarding specific
antibiotic management and supportive care although it is
recognised that these are contextual to the prevalent organ-
isms and spectrum of infections. First-line antibiotics indi-
cated in the manual are ampicillin (50 mg/kg every
12 hours if aged ≤7 days, but every 8 hours if aged
>7 days) and gentamicin (5 mg/kg once daily if aged
≤7 days, but 7.5 mg/kg once daily if aged >7 days).
In nosocomial sepsis, the flora of the local NICU must
be considered and first-line antibiotic choice must vary
depending on resistance patterns.37
Anaemia requiring transfusion
The group could not reach consensus on a common defini-
tion of anaemia. The threshold for treatment of anaemia of
prematurity was then decided on the basis of criteria devel-
oped by the US and Canadian collaborative study, namely
to transfuse infants with a volume of 15 ml/kg, adminis-
tered over 2–3 hours.38
Neurological complications
Hypoxic ischaemic encephalopathy
Hypoxic ischaemic encephalopathy is a clinically defined
syndrome of disturbed neurological function in the earliest
days of life in the term infant, manifested by difficulty with
initiating and maintaining respiration, depression of tone
and reflexes, subnormal level of consciousness and often
seizures.
The cornerstone of treatment is supportive care and
careful maintenance of systemic homeostasis39 even if the
management of each asphyxiated baby is individualised.
Given the importance of hypoxic ischaemic encephalopathy
aftercare, guidelines are provided in the manual about
appropriate fluid and electrolyte management, timing and
dosage of vasopressors to maintain adequate perfusion and
treatment of seizures if needed, with general recommenda-
Table 3. Management recommendations for apnoea of prematurity
Clinical condition Management recommendations
Apnoea of prematurity General measures: tactile stimulation, correct anaemia, maintain normal body temperature; look for electrolyte
imbalance, intraventricular haemorrhage, signs or symptoms of sepsis, patent ductus arteriosus, necrotising
enterocolitis and gastro-oesophageal reflux, and treat it accordingly.
Specific treatment: theophylline or caffeine, depending on availability and neonatologist’s preference. Aminophylline:
5–6 mg/kg orally or intravenously (infused over 15–30 minutes) as a loading dose, followed by a maintenance dose
of 2 mg/kg starting 12 hours after the loading dose. Caffeine: 20 mg of caffeine citrate (10 mg of caffeine base)
orally or intravenously as a loading dose, followed by a maintenance dose of 2.5–5 mg/kg/day as a single dose
of caffeine base.
Therapy discontinuation: gestational age >37 weeks with weight of 1800–2000 g, or if the infant has been apnoea
free for 7 days.
Failure of drug therapy: use nasal Continuous Positive Airway Pressure (nCPAP) at a rate of 2–4 cm H2O or high-flow
nasal cannula at 1–2 l/minute and continue administration of the drug. If apnoea and bradycardia cannot be
controlled by drug therapy or nCPAP, consider mechanical ventilation with low pressures.
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tions about gastrointestinal care and when to start enteral
nutrition, based on recent evidence.40
Screening for intraventricular haemorrhage and
periventricular leukomalacia
Based on a review of the literature and expert opinion,
routine screening for intraventricular haemorrhage or
periventricular leukomalacia is recommended only in new-
borns <30 weeks of gestation, after the first 7–14 days of
life and thereafter at 36–40 weeks of gestation or just
before discharge.41 However, we anticipated that this would
be an uncommon occurrence within the context of the
INTERGROWTH-21st Project.
Continuation of feeding for the preterm infant
As anticipated in the section above on initiation of feeding,
the goal is breastfeeding promotion for the preterm infant at
the time of hospital discharge. In addition, the ideal duration
of exclusive breastfeeding is 6 months in low-birthweight
infants, accompanied by adequate supplementation27 (e.g.
vitamin D 400 IU/day if birthweight <1500 g).
The issue of exclusive breastfeeding at discharge was thor-
oughly discussed at the last Neonatal Group Meeting, in
April 2011, for its relevance to the INTERGROWTH-21st
Project. We concluded that it is vital for the participating
centres to implement exclusive breastfeeding strategies for all
the infants enrolled. The first steps are to increase awareness
and educate all healthcare professionals about the benefits of
human milk and breastfeeding support in the mothers of
preterm infants. Thereafter, establishing a strong relationship
between the family and the local investigator is recom-
mended, and the investigator should be available for breast-
feeding counselling and encouragement.
To monitor implementation, each participating centre is
asked to report its breastfeeding rates; the data and any barri-
ers to implementation are then discussed on a regular basis.
Evidence-based implementation of the
basic neonatal care manual and
protocols
To assist care providers with decisions about appropriate
health care in the clinical circumstances described above, it
was important not only to develop valid recommendations
based on current evidence, but also to ensure the imple-
mentation of the evidence-based recommendations.
According to A Guideline Developer’s Handbook, published
by the Scottish Intercollegiate Guidelines Network,42 the
main external barriers to implementation are structural fac-
tors such as financial disincentives, organisational issues
(e.g. lack of facilities or equipment), local standards of care
not in line with desired practice and individual factors (e.g.
knowledge, attitude and skills).
Specific efforts were made in the context of the
INTERGROWTH-21st Project to overcome such external
barriers to implementation. First, we ensured there was
adequate financial support for, and standardisation of,
locally qualified human resources. Second, the availability
of facilities and equipment was checked before the project
started. Third, during the initial implementation of the
project, the Neonatal Group confirmed that local practices
were not in conflict with our recommendations by asking a
neonatologist (AH) to assist the Chair (ZAB) in obtaining
information about local capacity and standards of care.
Finally, successful implementation depends upon the local
quality of human resources and ability to follow standar-
dised guidelines; although this is always challenging, there
are measures in place to ensure ready communication and
coordination between the Neonatal Group and the centres.
During the April 2011 meeting, the group discussed issues
pertaining to implementation, such as the breastfeeding
strategy described above. Subsequently, a neonatologist (FG)
was put in charge of implementing the manual and coordi-
nating PPFS within the centres. Implementation included
translation of the manual as required (e.g. Italy, China), and
identification of a local neonatologist as the PPFS coordina-
tor, who could present the manual to the medical and nurs-
ing staff in each NICU. A comparison between local NICU
protocols and the guidelines presented in the manual was
then performed and issues were discussed with the PPFS
coordinator. In this respect, it is relevant to say that the man-
ual describes a basic level of care and does not represent a
strict protocol; so, local higher level of care (e.g. sophisti-
cated ventilation, surfactant therapy, selective hypothermia
for asphyxiated newborns) was readily accepted.
Conclusions
Building prescriptive standards requires that the population
selected has the best potential for growth, and receives ade-
quate standardised nutrition and evidence-based clinical
care. As regards nutrition, the goal is the promotion of
exclusive breastfeeding of the preterm infant at the time of
hospital discharge, ideally continued exclusively for
6 months. In addition, all preterm infants should receive
standardised, evidence-based, medical care across all the
neonatal units involved and the study follow-up clinics.43
This can be achieved only through adequate coordination
among the local neonatologists in the participating centres
and by following the operations manual for clinical practice
developed by the Neonatal Group.5 The crucial importance
of sharing and implementing the manual lies mainly in the
promotion of exclusive breastfeeding, which also involves
counselling families, and in the standardisation of clinical
care among units in different geographical areas, both of
which are essential from a global perspective.44
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Although restricted to the study groups themselves, the
process of agreeing on common definitions and protocols for
the care of newborns, including preterm infants, was unique
and informative. Despite diverse backgrounds and contexts
spanning five continents, investigators were able to agree
upon common protocols and implement them. The INTER-
GROWTH-21st Basic Neonatal Care Manual presents up-
to-date clinical guidelines based on reviews of the published
evidence and is therefore a valuable tool to improve stan-
dards of clinical care in developing countries. It should be
recognised that these represent aspirational guidelines and
would need to be adapted by countries to suit specific needs
in district and referral hospitals. However, at least in one
instance in Pakistan, the manual has been used to develop
national guidelines for hospital-based care for newborns in
the district.45 With increasing interest in newborn care in
developing countries at various levels of care, this manual
should complement developing guidelines by agencies such
as WHO for the hospital care of children and newborns.46
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